Randomized and comparative evidence for PEMF / pulsed shortwave therapy in knee and cervical osteoarthritis.
Randomized double-blind placebo-controlled trial (n=60) of wearable PEMF therapy worn 12 hours/day for one month in symptomatic knee OA.
Randomized parallel-arm trial comparing wearable PSWT against COX-2 NSAID therapy over four weeks; PSWT group showed superior NDI/VAS improvement and zero adverse events.
Looking for the over-the-counter device? View ActiPatch® and pack options. For wear and safety questions, visit the ActiPatch® FAQ.